top of page
NMDAR-Antibody Encephalitis: A new clinical way to identify patients
A transdiagnostic pattern of psychiatric symptoms in autoimmune encephalitis
The psychopathology of NMDAR-antibody encephalitis in adults
RECOGNIZING PSYCHIATRIC PRESENTATIONS OF ANTI-NMDA RECEPTOR ENCEPHALITIS
Anti-NMDAR encephalitis with concomitant varicella zoster virus detection and nonteratomatous malignancy
Decreased occipital lobe metabolism by FDG-PET/CT
Mouse model of anti-NMDA receptor post–herpes simplex encephalitis
A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis
EEG findings in NMDA encephalitis – A systematic review
NMDAR Encephalitis: A Possible Pathophysiological Model For Pediatric Neuropsychiatric Disorders
Predictive value of electroencephalography in anti-NMDA receptor encephalitis
Frequency, symptoms, risk factors, and outcomes of Autoimmune Encephalitis
The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study
Monoclonal antibodies from a patient with anti‐NMDA receptor encephalitis
Anti–NMDAR encephalitis in a patient with Crohn disease receiving adalimumab
Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection
Membrane-bound and soluble forms of an NMDA receptor extracellular domain retain epitopes targeted in auto-immune encephalitis
NMDA Receptor Autoantibodies in Autoimmune Encephalitis Cause a Subunit-Specific Nanoscale Redistribution of NMDA Receptors
Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong
Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis
Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis
Ovarian teratoma associated Anti-N-methyl-D-aspartate receptor encephalitis
Early identification of anti-NMDA receptor encephalitis presenting cerebral lesions in unconventional locations on magnetic resonance imaging
Magnetic resonance imaging and positron emission tomography in anti-NMDA receptor encephalitis: A systematic review
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets
Cerebrospinal fluid pentraxin 3 and CD40 ligand in anti-N-menthyl-d-aspartate receptor encephalitis
Anti-N-methyl-D-aspartate receptor encephalitis associated with acute Toxoplasma gondii infection
Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong
Anti-NMDA receptor encephalitis presenting as postpartum psychosis—a clinical description and review
N-methyl-D-aspartate receptor antibody production from germinal center reactions: therapeutic implications
N‐methyl‐D‐aspartate receptor antibody production from germinal center reactions: Therapeutic implications
Treatable Immune System Disorder Could Be Mistaken For Schizophrenia or Bipolar Disorder
Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis
Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis
Non-inflammatory cerebrospinal fluid delays the diagnosis and start of immunotherapy in anti-NMDAR encephalitis
Suicidality is a common and serious feature of anti-N-methyl-D-aspartate receptor encephalitis
Arterial spin labeling perfusion imaging demonstrates cerebral hyperperfusion in anti-NMDAR
High sensitivity and specificity in proposed clinical diagnostic criteria for anti-NMDAr
Second Opinion: Mystery Diagnosis IV
Dynamic disorganization of synaptic NMDA receptors triggered by Abs from psychotic Pts
Serum complement levels in anti-N-methyl-D-aspartate receptor encephalitis
Decreased occipital lobe metabolism by FDG-PET/CT anti–NMDAr encephalitis biomarker
Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR
Cell- and Single Molecule-Based Methods to Detect Anti-NMDAr Abs in Patient w/ psychosis
What is the promise of Bortezomib in refractory anti-NMDA receptor encephalitis?
Superficial white matter damage in anti-NMDA receptor encephalitis
NMDA- indications for testing and how it is diagnosed
Functional connectivity of large-scale brain networks in patients with anti-NMDAr encephalitis
NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody
Persistence of parenchymal and perivascular T-cells in treatment-refractory anti-N-methyl-D-aspartate receptor encephalitis
Persistence of parenchymal and perivascular T-cells in treatment-refractory NMDAr
UPENN~ Anti-NMDAR Encephalitis What is anti-NMDA Receptor Encephalitis?
Recent updates in Anti-NMDA Receptor Encephalitis Research
Comparative Outcomes in Children and Adults with anti-NMDA Receptor Encephalitis
Progressive hippocampal sclerosis after viral encephalitis: Potential role of NMDA receptor
What is the evidence to support the use of plasma exchange as first‐line therapy for NMDAr antibody encephalitis?
NMDA-receptor antibodies alter cortical microcircuit dynamics
Anti-NMDA Receptor Encephalitis Research 2017
Anti-N-Methyl-D-aspartate Receptor Encephalitis: A Severe, Potentially Reversible Autoimmune Encephalitis
Pathogen-mediated NMDAr autoimmunity and cellular barrier dysfunction in schizophrenia
Cognitive outcomes following anti-NMDAr encephalitis: A systematic review
anti-NMDAr encephaltis coexisting with NMO disorder or neurosyphilis
Ovarian teratoma development after anti-NMDA receptor encephalitis treatment
CSF cyto-/chemokine profile during acute HSV induced anti-NMDAr and in chronic sequelae
Herpes simplex virus-induced anti-NMDA receptor encephalitis: a systematic literature review
NMDAr: Untangling Apparant Inconsistencies for Clinical Practice
First reported cases of anti-NMDAr encephalitis in Vietnamese adolescents and adults
First reported cases of anti-NMDAr encephalitis in Vietnamese adolescents and adults
Bortezomib for Treatment of Anti-NMDA Receptor Encephalitis
Differences in treatment of anti-NMDA receptor encephalitis: results of a worldwide survey
Anti-NMDA Receptor Antibody positivity A Systematic Review of the Literature
NMDAr presents in atypical types
What is Anti-NMDA Receptor Encephalitis?
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
What is Anti-NDMA Receptor Encephalitis?
NMDAr autoimmunity affects cognitive performance in herpes simplex encephalitis
Anti-NMDA receptor encephalitis: An emerging differential diagnosis in the psychiatric community
Recognizing anti-NMDA receptor encephalitis psychosis on the psych ward
Potentially effective off-label: Bortezomib Treatment for Patients With NMDAr
Anti–NMDAr Encephalitis: A Potential Mimic of Neuroleptic Malignant Syndrome
Variations of movement disorders in anti-NMDAr encephalitis: A nationwide study in Taiwan
Not So Rare But rarely Dx: From Demonic Possession to Anti-NMDr
NMDAr subunit NR1 abs have pathogenic potential irrespective of epitope and immunoglobulin class
Promising results from animal model research in NMDAr w/ many potential applications
All abs against the NMDAr subunit NR1 have pathogenic potential irrespective of epitope & Ig class
New onset Headache in Patients W/ AE associated w/ NMDAr antibodies
The genetic sibling of NMDA receptor encephalitis
Structural Hippocampal Damage Following Anti-N-Methyl-D-Aspartate Receptor Encephalitis
First-episode psychosis in a 15 year-old female with clinical presentation of anti-NMDAr
Anti-NMDA Receptor Encephalitis: A Need for Increased Awareness Among Psychiatrists
NMDAr encephalitis following Herpes Simplex Encephalitis Appear Different in Adults than in Children
Intravenous methylprednisolone versus therapeutic plasma exchange for treatment of NMDA
Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus)
Anti-NMDA-receptor encephalitis: A neuropsychiatric syndrome associated with ovarian teratoma
CSF findings in patients with anti-N-methyl-d-aspartate receptor-encephalitis
Molecular Pathogenesis of Anti-NMDAR Encephalitis
Mayo Unravels a Mystery Disease For Minnisota Attorney
anti-NMDAr concomitant with multifocal subcortical white matter lesions on MRI
anti-NMDAr encephalitis: review of clinical presentation, diagnosis and treatment
Blood and CSF test for NMDA: Test results for CSF is 100% but Blood 87.5-94.7%.
Overview of Anti-NMDA Receptor Encephalitis
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis
Herpes simplex virus encephalitis is a trigger of brain autoimmunity
Increased prevalence of diverse NMDAr antibodies in patients with an initial dx of schizophrenia
Diagnostic value of CSF findings in antibody-associated limbic and anti-NMDAR-encephalitis
Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study
Newly diagnosed brain disease may be misdiagnosed as psychological disorder
Association between the NMDA glutamate receptor GRIN2B gene and obsessive–compulsive disorder
Parents warn of mystery illness misdiagnosed in kids (NMDA)
N-methyl D-aspartate receptor encephalitis: A new addition to the spectrum of autoimmune encephalitis
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis
All naturally occurring autoantibodies against the NMDA receptor (discusses BBB permeability)
bottom of page